The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes and safety in patients with VHL associated tumors receiving belzutifan.
 
Anusha Chidharla
No Relationships to Disclose
 
Ryan Fleer
No Relationships to Disclose
 
Madison Murphy
No Relationships to Disclose
 
Kelly Brunk
No Relationships to Disclose
 
Jeffrey Holzbeierlein
Consulting or Advisory Role - Basilea; KDx Diagnostics
Research Funding - MDxHealth (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Medivation
 
Anup Kasi
Consulting or Advisory Role - Ipsen
Research Funding - Ability Pharma (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Myovant Sciences (I)
Consulting or Advisory Role - Merck
Research Funding - Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.